# Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/sponsor-responsibilities-safety-reporting-requirements-and-safety-assessment-for-ind-and-bioavailabilitybioequivalence-studies-guidance-for-industry/de07fd31-d42a-4c2e-8af7-ae503e60bcbc

> FDA guidance document: Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies:  Guidance for Industry. Issue date: December 15, 2025. Get complete insights and analysis.

---

## Details

- Title: Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-12-15
- Comment Close Date: 2021-09-24
- Last Changed: 2025-12-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-2099">FDA-2020-D-2099</a>

## Related Documents

- [Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-endpoints-for-the-approval-of-cancer-drugs-and-biologics-guidance-for-industry/2ab76b05-d847-445c-b212-0047a592f760)
- [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335)
- [Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format](https://www.globalkeysolutions.net/guidances/guidance-document/patient-counseling-information-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/91c267ae-e99d-4508-b31c-721b7da25d2b)